PharmStockPharmacy Stock

Sprycel
Sprycel

129
Used to address oncology care, this generic medicine targets specific protein kinases to inhibit abnormal cellular growth patterns.
Ingredient
Dasatinib
Category
Oncology Support
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Dasatinib
Reference Brand
Dasatinib
Product Origin
Generic Alternative
Reference Manufacturer
Bristol-Myers Squibb
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief
Product Category
Tyrosine Kinase Inhibitor
Pharmacological Class
Antineoplastic
Manufacturer Description
Developed to mitigate malignant cell growth to support hematological safety and target tyrosine kinase activity.
Mechanism of Action
Inhibits multiple oncogenic kinases, blocking cellular replication pathways in leukemia cells.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Severe hypersensitivity to dasatinib
Severe Adverse Events
Severe pleural effusion — requires immediate medical attention, Pulmonary arterial hypertension — requires immediate medical attention, Hemorrhage — requires immediate medical attention
Common Side Effects
Headache, Nausea, Fatigue
Uncommon Side Effects
Fluid retention, Myelosuppression, Skin rash
Drug Interactions
Ketoconazole, Rifampin, Antacids
Pregnancy Safety Warnings
TGA Category D: High risk of fetal harm. Avoid. Breastfeeding: Contraindicated.
Age Restrictions
Approved for children and adults based on indication.
Storage Guidelines
Store below 25°C.
Related Products
Gleevec
Information related to Sprycel is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to buy Stop Smoking Treatment - Buy Bupropion AU